NDAOPHTHALMICOINTMENT1 Generic Approved
Approved
Mar 1998
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Data completeness
2/8 — Basic
Drug data last refreshed 49m ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CILOXAN is a topical ophthalmic ointment formulation of ciprofloxacin hydrochloride, a fluoroquinolone antibiotic used to treat bacterial eye infections. It works by inhibiting bacterial DNA gyrase, preventing DNA replication in gram-positive and gram-negative ocular pathogens. The product has been approved since 1998 and remains a standard-of-care option for corneal ulcers, conjunctivitis, and other external eye infections.
LOE Approaching
Product is in late-stage maturity with LOE approaching; brand teams should expect transitional restructuring and focus shift toward generic defense and line extension strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CILOXAN offers stability in a well-established therapeutic category but limited growth upside due to LOE approaching; roles emphasize defensive positioning, market access, and generic transition management. Career value lies in gaining expertise in mature product lifecycle management, managed care negotiations, and ophthalmic market dynamics.
Brand ManagerSenior Medical Science Liaison
Worked on CILOXAN at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.